G907-1029 Screening compound: N-[(3-methoxyphenyl)methyl]-1-({1-[(4-methylphenyl)methyl]-1H-indol-2-yl}methyl)piperidine-4-carboxamide

G907-1029 Screening compound: N-[(3-methoxyphenyl)methyl]-1-({1-[(4-methylphenyl)methyl]-1H-indol-2-yl}methyl)piperidine-4-carboxamide
G907-1029 Screening compound: N-[(3-methoxyphenyl)methyl]-1-({1-[(4-methylphenyl)methyl]-1H-indol-2-yl}methyl)piperidine-4-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound G907-1029
N-[(3-methoxyphenyl)methyl]-1-({1-[(4-methylphenyl)methyl]-1H-indol-2-yl}methyl)piperidine-4-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

G907-1029

Molecular Formula

C31H35N3O2 (C31 H35 N3 O2)

Compound Name

N-[(3-methoxyphenyl)methyl]-1-({1-[(4-methylphenyl)methyl]-1H-indol-2-yl}methyl)piperidine-4-carboxamide

IUPAC name

N-[(3-methoxyphenyl)methyl]-1-({1-[(4-methylphenyl)methyl]-1H-indol-2-yl}methyl)piperidine-4-carboxamide

SMILES

Cc1ccc(Cn(c(CN(CC2)CCC2C(NCc2cc(OC)ccc2)=O)c2)c3c2cccc3)cc1

InChI

InChI=1S/C31H35N3O2/c1-23-10-12-24(13-11-23)21-34-28(19-27-7-3-4-9-30(27)34)22-33-16-14-26(15-17-33)31(35)32-20-25-6-5-8-29(18-25)36-2/h3-13,18-19,26H,14-17,20-22H2,1-2H3,(H,32,35)

InChI Key

HSQYSYPNKJTTKU-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD15074922

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

481.64

Hydrogen Bond Acceptors Count

4.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

9.00

Number of Nitrogen and Oxygen Atoms

5

Partition Coefficient, logP

5.285

Distribution Coefficient, logD

3.187

Water Solubility, LogSw

-5.77

Polar Surface Area

36.863

Acid Dissociation Constant (pKa)

13.07

Base Dissociation Constant (pKb)

9.49

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

32.30

G907-1029 in Drug Discovery

Included in Screening Libraries

3D-Biodiversity Library (27607 compounds)

Anti-infective Library (19449 compounds)

CNS Targets (44014 compounds)

CNS targets activity set (6557 compounds)

CORONAVIRUS Library (20774 compounds)

MCL1 Targeted Library (12200 compounds)

PLpro Library (6343 compounds)

ChemoGenomic Annotated Library for Phenotypic Screening (89798 compounds)

Ion Channels Focused Library (26372 compounds)

Target Identification, Phenotypic Screening library (TIPS) (27612 compounds)

Included in 1.7M Stock Database

Structure:
  • 3D
Therapeutical areas:
  • Infections
  • Immune system
  • animal
  • Nervous system
  • Antiviral
  • Infections
  • Immune system
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Antiviral
  • Infections
  • Immune system
  • Nervous system
  • Cardiovascular
Targets:
  • Ion Channels

References: we are preparing a list of scientific research reports with G907-1029 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound G907-1029?
Check Price and Availability of G907-1029, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of G907-1029 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for G907-1029
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for G907-1029
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of G907-1029 available by request